These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 8429321
1. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. Vermeulen M, van Doorn PA, Brand A, Strengers PF, Jennekens FG, Busch HF. J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):36-9. PubMed ID: 8429321 [Abstract] [Full Text] [Related]
3. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. van Doorn PA, Brand A, Strengers PF, Meulstee J, Vermeulen M. Neurology; 1990 Feb; 40(2):209-12. PubMed ID: 2405291 [Abstract] [Full Text] [Related]
4. Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC). Bus SRM, Zambreanu L, Abbas A, Rajabally YA, Hadden RDM, de Haan RJ, de Borgie CAJM, Lunn MP, van Schaik IN, Eftimov F, OPTIC study group. Trials; 2021 Feb 19; 22(1):155. PubMed ID: 33608058 [Abstract] [Full Text] [Related]
5. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Nobile-Orazio E, Cocito D, Jann S, Uncini A, Beghi E, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Macchia R, Cavaletti G, Giannini F, Sabatelli M, IMC Trial Group. Lancet Neurol; 2012 Jun 19; 11(6):493-502. PubMed ID: 22578914 [Abstract] [Full Text] [Related]
6. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. van Doorn PA. J Neurol Neurosurg Psychiatry; 1994 Nov 19; 57 Suppl(Suppl):38-42. PubMed ID: 7964851 [Abstract] [Full Text] [Related]
7. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial. van Schaik IN, van Geloven N, Bril V, Hartung HP, Lewis RA, Sobue G, Lawo JP, Mielke O, Cornblath DR, Merkies IS, PATH study group. Trials; 2016 Jul 25; 17(1):345. PubMed ID: 27455854 [Abstract] [Full Text] [Related]
8. A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol. Cornblath DR, Hartung HP, Katzberg HD, Merkies ISJ, van Doorn PA. J Peripher Nerv Syst; 2018 Jun 25; 23(2):108-114. PubMed ID: 29603842 [Abstract] [Full Text] [Related]
9. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group. Fazekas F, Deisenhammer F, Strasser-Fuchs S, Nahler G, Mamoli B. Lancet; 1997 Mar 01; 349(9052):589-93. PubMed ID: 9057729 [Abstract] [Full Text] [Related]
10. Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study. Markvardsen LH, Sindrup SH, Christiansen I, Olsen NK, Jakobsen J, Andersen H, Danish CIDP and MMN Study Group. Eur J Neurol; 2017 Feb 01; 24(2):412-418. PubMed ID: 28000311 [Abstract] [Full Text] [Related]
11. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN. Cochrane Database Syst Rev; 2009 Jan 21; (1):CD001797. PubMed ID: 19160200 [Abstract] [Full Text] [Related]
12. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Mendell JR, Barohn RJ, Freimer ML, Kissel JT, King W, Nagaraja HN, Rice R, Campbell WW, Donofrio PD, Jackson CE, Lewis RA, Shy M, Simpson DM, Parry GJ, Rivner MH, Thornton CA, Bromberg MB, Tandan R, Harati Y, Giuliani MJ, Working Group on Peripheral Neuropathy. Neurology; 2001 Feb 27; 56(4):445-9. PubMed ID: 11222785 [Abstract] [Full Text] [Related]
13. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. Van den Berg LH, Kerkhoff H, Oey PL, Franssen H, Mollee I, Vermeulen M, Jennekens FG, Wokke JH. J Neurol Neurosurg Psychiatry; 1995 Sep 27; 59(3):248-52. PubMed ID: 7673950 [Abstract] [Full Text] [Related]
14. Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study). Kuitwaard K, Fokkink WR, Brusse E, Vrancken AFJE, Eftimov F, Notermans NC, van der Kooi AJ, Merkies ISJ, Jacobs BC, van Doorn PA. J Peripher Nerv Syst; 2018 Mar 27; 23(1):5-10. PubMed ID: 29119642 [Abstract] [Full Text] [Related]
19. Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy. Kuitwaard K, van den Berg LH, Vermeulen M, Brusse E, Cats EA, van der Kooi AJ, Notermans NC, van der Pol WL, van Schaik IN, van Nes SI, Hop WC, van Doorn PA. J Neurol Neurosurg Psychiatry; 2010 Dec 27; 81(12):1374-9. PubMed ID: 20587484 [Abstract] [Full Text] [Related]
20. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Léger JM, Chassande B, Musset L, Meininger V, Bouche P, Baumann N. Brain; 2001 Jan 27; 124(Pt 1):145-53. PubMed ID: 11133794 [Abstract] [Full Text] [Related] Page: [Next] [New Search]